Skip to main content
. 2022 Jul 20;1(4):273–281. doi: 10.1016/j.jacig.2022.05.007

Table I.

Baseline characteristics of participants

Characteristic GSTM1 null GSTM1 present P value
No. 5 5
Sex (M/F) 2/3 3/2
Age (years) 41.0 ± 5.9 29.6 ± 5.2 .01
Height (cm) 173.5 ± 7.1 167.6 ± 10.5 .32
Weight 102.5 ± 27.3 89.1 ± 23.0 .42
BMI (kg/m2) 34.12 ± 9.09 31.39 ± 6.34 .59
BSA (m2) 2.15 ± 0.26 1.98 ± .30 .35
PC20 1.79 ± 2.23 0.81 ± 0.87 .38
FEV1 (L) 3.19 ± 0.77 3.16 ± 0.55 .94
FEV1 percent predicted 85.4 ± 21.41 89.8 ± 13.01 .70
FVC (L) 4.46 ± 0.76 4.07 ± 0.73 .43
FVC percent predicted 94.8 ± 9.93 97.0 ± 9.46 .72
Ratio (FEV1/FVC) 0.72 ± 0.14 0.78 ± 0.07 .41

Data shown are means ± SDs. Participants were all asthmatic and atopic. BMI, Body mass index; BSA, body surface area.